| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2023 12-31 |
2022 12-31 |
2021 12-31 |
2020 12-31 |
2019 12-31 |
|---|---|---|---|---|---|---|---|
| Report Filing | 2025-11-06 | 2025-03-07 | 2024-03-08 | 2023-03-16 | 2022-03-29 | 2020-12-31 | 2019-12-31 |
| Revenue | 582.8 | 604.1 | 605.9 | 655.9 | 785.5 | 545.8 | 363.3 |
| Cost of Revenue | 357.7 | 348.6 | 382.3 | 427.1 | 484.8 | 311 | 207.5 |
| Gross Profit | 225.1 | 255.5 | 223.6 | 228.8 | 300.8 | 234.8 | 155.8 |
| Operating Expenses | 230.4 | 258.4 | 279 | 574.7 | 361.9 | 176.5 | 145.3 |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative | 200.5 | 223.1 | 238.5 | 297.5 | 323.7 | 143.9 | 112.2 |
| Other Operating Expenses | 29.92 | 35.27 | 40.48 | 277.2 | 38.18 | 32.53 | 33.1 |
| Operating Income | -5.35 | -2.94 | -55.45 | -345.9 | -61.15 | 58.35 | 10.46 |
| Net Non-Operating Interest | -31.99 | -33.5 | -31.27 | -27.89 | -26.65 | -34.07 | -39.46 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 31.99 | 33.5 | 31.27 | 27.89 | 26.65 | 34.07 | 39.46 |
| Equity & Other Income/(Expense) | -71.88 | 0.48 | 4.3 | -7.13 | -2.48 | 7.53 | -0.462 |
| Income Before Tax | -109.2 | -35.96 | -82.42 | -381 | -90.28 | 31.8 | -29.47 |
| Income Tax Expense | -4.28 | -1.96 | 1.99 | 1.19 | 1.49 | 0.749 | 0.124 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -104.9 | -34.01 | -84.4 | -382.1 | -91.77 | 31.05 | -29.59 |
| Depreciation and Amortization | 54.55 | 56.33 | 57.78 | 56.55 | 47.5 | 40.97 | 39.16 |
| EBITDA | 49.2 | 53.38 | 2.33 | -289.4 | -13.65 | 99.31 | 49.61 |
| Earnings Per Share (EPS) | -0.785 | -0.27 | -0.68 | -3.19 | -0.79 | 0.26 | -0.25 |
| Diluted Earnings Per Share | -0.785 | -0.27 | -0.68 | -3.19 | -0.79 | 0.26 | -0.25 |
| Weighted Average Shares Outstanding | 134.2 | 127.4 | 123.7 | 119.7 | 112.4 | 117.5 | 117.5 |
| Diluted Weighted Average Shares Outstanding | 134.2 | 127.4 | 123.7 | 119.7 | 112.4 | 117.5 | 117.5 |
